As of Nov 19, 2026, 1 of 1 active firms rate NBP a Buy (0 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
Top analysts covering NovaBridge Biosciences
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on NBP.
#1
Andres Y. Maldonado
HC Wainwright & Co. · Rank #288
Buy
$9.00+912.3% to target
Overall win rate
39%
+ Follow
#2
Daina Graybosch
Leerink Partners · Rank #396
Buy
$9.00+912.3% to target
Overall win rate
41%
+ Follow
#3
Justin Zelin
BTIG · Rank #495
Buy
$9.00+912.3% to target
Overall win rate
30%
+ Follow
#4
KR
Kumaraguru Raja
Brookline Capital Markets
Buy
$8.00+799.8% to target
Coverage
—
+ Follow
#5
CL
Christopher Liu
Lucid Capital
Buy
$5.00+462.4% to target
Coverage
—
+ Follow
NBP stock forecast FAQ
What is NBP's average 12-month price target?+
The 1 active firms with a live target average $9.00 for NovaBridge Biosciences over the next 12 months, ranging from a $9.00 high to a $9.00 low, as of Nov 19, 2026.
Is NBP stock a Buy, Sell or Neutral right now?+
The current consensus is Insufficient coverage. Of the 1 active firms as of Nov 19, 2026, 1 rate it Buy or Strong Buy, 0 rate it Neutral, and 0 rate it Sell or Strong Sell.
How many active Wall Street firms cover NBP?+
1 active firms have a recognized rating on NovaBridge Biosciences as of Nov 19, 2026, and 1 active firms carry a live 12-month price target.
Who is the most accurate analyst covering NBP?+
Among analysts who currently cover NBP, Andres Y. Maldonado of HC Wainwright & Co. has the strongest overall Quantellect track record (Rank #288). Their current call is Buy with a $9.00 target.
Have analysts been upgrading or downgrading NBP lately?+
As of Nov 19, 2026, 1 of 1 active firms rate NBP a Buy (0 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their NBP calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.